In order to further investigate whether CD24 cell surface expression could implicate tumor sensitivity to anti-IGF1R therapy, we inoculated CD24- and CD24+ cells with and without IGF1R-KD into the mammary fat pad of WT and the hyperinsulinemic MKR female mice. The gene discussed is CD24; the disease is neoplasm.